Summary of Purpose
The primary objective of this multicenter observational study is to determine the effect size of the relationship between DCI and neuropsychological impairment 14-28 days and 3 months after aSAH. Secondary objectives are the feasibility to administer and the validity of the MoCA in an intensive care unit setting, as well as the test/retest reliability of the MoCA in patients with acute brain damage in...Read More →
The following dates are available for this trial. Trial information last updated on 3 October 2017.
|20 Jul 2017||20 Jan 2017||1 Jul 2019||1 Oct 2019||1 Jul 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- There is no intervention for this study. Patients are allocated to the study groups based on whether or not DCI occurs.
Conditions See All
Sponsors See All